Description
In This Episode:
- Richard Pazdur, MD, Director, FDA Oncology Center of Excellence
- Lola Fashoyin-Aje, MD MPH, Deputy Division Director, FDA
- Tanios Bekaii-Saab, Professor, Mayo Clinic College of Medicine and Science
- Peter Langmuir, MD, Vice President, Oncology Drug Development, Incyte
- Stacie Lindsey, Founder, Cholangiocarcinoma Foundation
- Andrea Parrella, M Ed, patient representative
|
Name |
Financial Relationships | Disclosure Type | Role |
| R. Pazdur | No Relationships | Program Committee, Speaker | |
| L. Fashoyin-Aje | No Relationships | Speaker | |
| T. Bekaii-Saab | Incyte, Taiho, Janssen | Consultant, Grant /research support recipient | Speaker |
| P. Langmuir | Incyte | Employee | Speaker |
| S. Lindsey | No Relationships | Speaker | |
| A. Parrella | No Relationships | Speaker |
FDA staff involved in the development and review of this activity have disclosed no relevant financial relationships.
AACR staff involved in the development and review of this activity have disclosed no relevant financial relationships.
Questions About CE?
Please contact the Office of CME at (215) 440-9300 or cme@aacr.org.PEMIGATINIB PRESCRIBING INFORMATION